SCHEMBL3693771

SCHEMBL3693771

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C/CCC(CO)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
CNR1 P21554 3/20 0.46
CNR2 P34972 2/20 0.46
ADORA3 P0DMS8 2/20 0.40
NR1I2 O75469 1/20 0.40
PGR P06401 1/20 0.40
PTGS2 P35354 1/20 0.40
PDE4D Q08499 1/20 0.40
MAPT P10636 2/20 0.39
CYP19A1 P11511 2/20 0.39
RXRA P19793 2/20 0.39
PPARG P37231 2/20 0.39
OXER1 Q8TDS5 2/20 0.39
FFAR1 O14842 1/20 0.39
FAAH O00519 1/20 0.39
HPGD P15428 1/20 0.39
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878835 1.00 ALDH1A1 (0.46) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL3691366 0.88 ALDH1A1 (0.54) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL4456390 0.87 ALDH1A1 (0.53) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL3688962 0.87 ALDH1A1 (0.53) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL3691941 0.86 ALDH1A1 (0.55) ALDH1A1CNR1CNR2ADORA3MAPT
SCHEMBL3694351 0.84 ALDH1A1 (0.45) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL13169162 0.84 ALDH1A1 (0.44) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL3684216 0.84 ALDH1A1 (0.44) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL4558174 0.81 ALDH1A1 (0.41) ALDH1A1CNR1CNR2ADORA3NR1I2
SCHEMBL2872687 0.81 ALDH1A1 (0.41) ALDH1A1CNR1CNR2ADORA3NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240616-A1 NOVEL LIPID COMPOUNDS ELOVL3, FFAR3, STARD3 ALDH1A1 2317/4885CNR1 258/4885CNR2 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.